ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $433 | +279.8% | 12,156 | +390.4% | 0.01% | +400.0% |
| Q2 2023 | $114 | -88.4% | 2,479 | -89.9% | 0.00% | -90.9% |
| Q1 2023 | $982 | -11.1% | 24,486 | +2.8% | 0.01% | -15.4% |
| Q4 2022 | $1,104 | -99.9% | 23,827 | -31.5% | 0.01% | -27.8% |
| Q3 2022 | $1,441,000 | +12.3% | 34,803 | +61.8% | 0.02% | +28.6% |
| Q2 2022 | $1,283,000 | -5.0% | 21,507 | +15.6% | 0.01% | +40.0% |
| Q1 2022 | $1,351,000 | +788.8% | 18,602 | +928.3% | 0.01% | +900.0% |
| Q4 2021 | $152,000 | -15.6% | 1,809 | -9.3% | 0.00% | 0.0% |
| Q3 2021 | $180,000 | -98.6% | 1,994 | -98.5% | 0.00% | -98.4% |
| Q2 2021 | $13,071,000 | +762.2% | 137,084 | +929.4% | 0.06% | +662.5% |
| Q1 2021 | $1,516,000 | +239.1% | 13,317 | +312.3% | 0.01% | +300.0% |
| Q4 2020 | $447,000 | +29.9% | 3,230 | -22.7% | 0.00% | 0.0% |
| Q3 2020 | $344,000 | +9.6% | 4,181 | +4.1% | 0.00% | -33.3% |
| Q2 2020 | $314,000 | -45.7% | 4,017 | -69.1% | 0.00% | -40.0% |
| Q1 2020 | $578,000 | -10.7% | 12,998 | -14.2% | 0.01% | -16.7% |
| Q4 2019 | $647,000 | -22.3% | 15,151 | -22.1% | 0.01% | -14.3% |
| Q3 2019 | $833,000 | +91.9% | 19,461 | +184.8% | 0.01% | +133.3% |
| Q2 2019 | $434,000 | -96.5% | 6,834 | -96.2% | 0.00% | -97.4% |
| Q1 2019 | $12,571,000 | +4488.0% | 181,237 | +2775.4% | 0.12% | +5700.0% |
| Q4 2018 | $274,000 | +138.3% | 6,303 | +320.2% | 0.00% | +100.0% |
| Q3 2018 | $115,000 | -46.3% | 1,500 | -46.1% | 0.00% | -50.0% |
| Q2 2018 | $214,000 | +22.3% | 2,783 | -19.0% | 0.00% | +100.0% |
| Q1 2018 | $175,000 | +20.7% | 3,435 | +10.1% | 0.00% | 0.0% |
| Q4 2017 | $145,000 | -7.1% | 3,120 | +6.5% | 0.00% | 0.0% |
| Q3 2017 | $156,000 | -82.3% | 2,929 | -76.6% | 0.00% | -85.7% |
| Q4 2016 | $880,000 | +12.5% | 12,520 | +13.6% | 0.01% | -12.5% |
| Q3 2016 | $782,000 | +106.3% | 11,021 | +84.0% | 0.01% | +166.7% |
| Q1 2016 | $379,000 | -11.9% | 5,990 | +34.3% | 0.00% | 0.0% |
| Q3 2015 | $430,000 | +194.5% | 4,461 | +213.3% | 0.00% | +200.0% |
| Q2 2015 | $146,000 | -40.7% | 1,424 | -64.1% | 0.00% | 0.0% |
| Q1 2015 | $246,000 | +22.4% | 3,969 | -13.3% | 0.00% | 0.0% |
| Q4 2014 | $201,000 | +45.7% | 4,579 | +88.4% | 0.00% | 0.0% |
| Q3 2014 | $138,000 | – | 2,430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |